Cytofact's New IT Security
2025-07-04 02:59:49

Cytofact Introduces Innovative IT Security Solution to Optimize Device Management and Windows Updates

Introduction of AssetView Cloud+



Cytofact, a leading biotech firm based in Kobe, Japan, has recently announced the implementation of a cloud-based information security solution, AssetView Cloud+. This initiative aims to streamline device management and optimize Windows updates, a crucial requirement in the sensitive field of genetic and cellular pharmaceutical manufacturing.

Background of Cytofact and Its Operations



Founded as the Kobe Biomedical Innovation Cluster, Cytofact specializes in contract development and manufacturing of genetically engineered cell therapies, prominently known for its role in producing CAR-T therapy, namely Kimurai, the first commercially available drug of its kind in Asia. Its commitment to adhering to GMP (Good Manufacturing Practice) plays a vital role in ensuring the quality and safety of its products, thus providing a backbone for Japan's regenerative medicine and cellular treatment sectors.

In its operations, Cytofact faces unique challenges, particularly in information security due to the sensitive nature of its work. The company has adopted a segregated internal network structure, which complicates centralized device management through proxy-based systems. Moreover, the reliance on Windows Server Update Services (WSUS) for update management has also posed challenges, especially with the cessation of WSUS development announced for September 2024. Consequently, Cytofact evaluated several cloud-based solutions, ultimately deciding on AssetView Cloud+ due to its dependency-free execution of Windows updates and centralized management capabilities.

The Features of AssetView Cloud+



AssetView Cloud+ is designed around a human-centric approach to IT asset management, allowing organizations to efficiently manage their hardware, software, and licenses from a single platform. It is adaptable to various network configurations, thanks to its support for both HTTP/HTTPS communication and web proxies. One of the significant advantages of AssetView Cloud+ over traditional methods is its capability to facilitate Windows updates without the pitfalls associated with WSUS, such as unnecessary installations or data overloads. An automated system is in place to delete unused program data when disk capacity becomes constrained, thereby alleviating the operational burden on IT departments and enabling them to focus on more strategic tasks.

Additionally, the management console offers an intuitive interface, enhancing usability and clarity. Unlike conventional all-in-one software packages, AssetView Cloud+ can be tailored to meet individual operational goals and implemented as needed, maximizing investment efficiency by eliminating superfluous features.

About Cytofact



Cytofact serves as a crucial player in the biotechnology landscape of Japan, actively contributing to the infrastructure surrounding the pharmaceutical manufacturing sector. By prioritizing information security, the company ensures the integrity of its operations, setting a benchmark for quality in biomedical solutions.

For further details on Cytofact and its innovative solutions, please visit Cytofact's official website.

About Hammock Inc.



Hammock Inc., headquartered in Shinjuku, Tokyo, provides corporate software packages and cloud services. By focusing on creating innovative experiences through technology, Hammock aims to solve customer challenges effectively. Founded in April 1994, the company is committed to offering high-quality features promptly at a reasonable cost. Learn more about their offerings, including AssetView Cloud+ and other tools, at Hammock's official site.


画像1

画像2

画像3

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.